Picture of INVO Fertility logo

IVF — INVO Fertility News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

INVO Fertility Q2 revenue rises, partly on acquisitions

((This story was generated using AI and automation, please see
disclaimer https://bit.ly/rtrsnai))
Overview
    * US fertility clinic operator's Q2 revenue rose 17% yr/yr, driven by acquisitions and organic growth
    * Net income turned positive, aided by a gain on Birmingham clinic remeasurement
    * Adjusted EBITDA remained negative at -$1.0 mln, reflecting ongoing platform investments

Outlook
    * Company plans to drive organic growth across its existing clinic network
    * INVO Fertility continues to evaluate acquisition opportunities for established, profitable fertility clinics
    * Company investing in operations, HR, and finance to support expansion and improve scalability

Result Drivers
    * FAMILY BEGINNINGS ACQUISITION - Q2 revenue growth was primarily attributed to the addition of Family Beginnings following its February 2026 acquisition
    * ORGANIC CLINIC GROWTH - Continued growth initiatives at Wisconsin Fertility Institute and the Georgia clinic contributed to first-half revenue
    * BIRMINGHAM CLINIC OWNERSHIP - Gain on remeasurement and future economics resulted from acquiring full ownership of the Birmingham clinic

Company press release:  ID:nGNX37HlZY 
Key Details
 Metric    Beat/Mis  Actual    Consensu
           s                   s
                               Estimate
 Q2                  $2.18      
 Revenue             mln       
 Q2 Net              $888,740   
 Income                        
 Q2                  -$1.03     
 Adjusted            mln       
 EBITDA                        
 Reuters Recommended Reads
    * Aug 14 - Cancer diagnostics firm Precipio's Q2 revenue rises, adjusted EBITDA turns positive
    * Aug 14 - Healthy Extracts Q2 net revenue rises 113% on acquisitions
    * Aug 14 - Medical device maker Retractable Technologies' Q2 sales drop on weak EasyPoint needle orders

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on INVO Fertility

See all news